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Abstract
Human cytomegalovirus (HCMV) is a ubiquitous herpesvirus that is able to infect fibroblastic, epithelial, endothelial and
hematopoietic cells. Over the past ten years, several groups have provided direct evidence that dendritic cells (DCs) fully
support the HCMV lytic cycle. We previously demonstrated that the C-type lectin dendritic cell-specific intercellular adhesion
molecule-3-grabbing non-integrin (DC-SIGN) has a prominent role in the docking of HCMV on monocyte-derived DCs
(MDDCs). The DC-SIGN/HCMV interaction was demonstrated to be a crucial and early event that substantially enhanced
infection in trans, i.e., from one CMV-bearing cell to another non-infected cell (or trans-infection), and rendered susceptible
cells fully permissive to HCMV infection. Nevertheless, nothing is yet known about how HCMV enters MDDCs. In this study,
we demonstrated that VHL/E HCMV virions (an endothelio/dendrotropic strain) are first internalized into MDDCs by
a macropinocytosis-like process in an actin- and cholesterol-dependent, but pH-independent, manner. We observed the
accumulation of virions in large uncoated vesicles with endosomal features, and the virions remained as intact particles that
retained infectious potential for several hours. This trans-infection property was specific to MDDCs because monocyte-
derived macrophages or monocytes from the same donor were unable to allow the accumulation of and the subsequent
transmission of the virus. Together, these data allowed us to delineate the early mechanisms of the internalization and entry
of an endothelio/dendrotropic HCMV strain into human MDDCs and to propose that DCs can serve as a ‘‘Trojan horse’’ to
convey CMV from entry sites to other locations that may favor the occurrence of either latency or acute infection.
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Introduction
Human cytomegalovirus (HCMV) can infect virtually any target
cell of human origin; however viral transmission, systemic spread
and proliferation occur in different cell types: epithelial cells,
endothelial and hematopoietic cells and fibroblasts and smooth
muscle cells, respectively (see [1] for review). HCMV initiates
infection through a non-specific, low-avidity interaction with
heparan sulfate proteoglycans (HSPGs; [2]). Then, higher avidity
receptors, such as b2-microglobulin [3], HLA-B27 [4], annexin II
[5], CD13 [6,7], EGFR [8] or integrins [9] have been shown to
promote stable attachment but to varying degrees. Most of these
receptors have indeed been shown to play only minor roles
[10,11,12] or even no role at all in HCMV capture and entry
except for b1 integrins and to a lesser extent b3 integrins [13].
Indeed, b1 integrins have been shown to interact with HCMV
particles and to further trigger intracellular signaling through
a disintegrin-like motif of the envelope glycoprotein B (HCMV gB;
[13]). Interestingly, we previously reported that HCMV gB is also
a ligand for the C-type lectin receptor dendritic cell (DC) specific
ICAM-grabbing non-integrin (DC-SIGN; [14]). We demonstrated
that the DC-SIGN contribution was crucial because the blockade
of DC-SIGN by antibody-mediated neutralization was necessary
and sufficient to dramatically reduce (an 80 to 95% reduction) the
binding of HCMV to the cell surface and to impair the productive
infection of MDDCs by HCMV [14]. It now appears that HCMV
likely uses distinct cell surface receptors with docking or entry-
mediating properties, depending on the target cell.
Some animal viruses enter their host cells directly through
penetration, i.e. release of the viral capsid in the cytosol after
fusion between the viral envelope and the plasma membrane while
the majority of them depend on endocytic uptake followed by viral
penetration at the endosomal level. Endocytosis is a process by
which a cell engulfs molecules that cannot pass through the plasma
membrane. Endocytosis can occur via different mecanisms and
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particles. Virus entry by endocytosis has been shown to involve
clathrin, caveolin-1, lipid rafts, as well as Il-2, GEEC, ARF6, the
flotillin pathway, macropinocytosis or phagocytosis (see [15] for
review). Macropinocytosis is defined as an actin-dependent
endocytic process involving plasma membrane ruffles which
allowed internalization of fluid and particles in large uncoated
endocytic vesicles (see [15] and [16] for review). The steps of
HCMV internalization have only been partially elucidated
because they appear to vary according to the HCMV strain
tropism and the type of target cell. Although HCMV entry into
fibroblasts, epithelial and endothelial cells has been shown to use
distinct pathways [16,17,18,19], nothing is known about the entry
of HCMV into dendritic cells (DCs). It has been noticed that
fibroblast infection is independent on actine polymerization
whereas infection of endothelial cells and retinal pigment epithelial
cells (RPE) is actin-dependent [17]. HCMV enters fibroblasts by
direct fusion to the plasma membrane in a pH-independent
manner [20]. Wild-type TR strain enters epithelial and endothelial
cells by endocytosis, in this process the fusion requires endosome
acidification [18]. Furthermore, it has been shown that HCMV
can enter RPE cells by two distinct pathways depending on which
cell type the virus is produced. A virus produced in epithelial cells
will preferentially enter target RPE cells via fusion to the plasma
membrane whereas virion generated in fibroblasts will enter by
endocytosis [19]. A recent paper also demonstrates the importance
of an intact UL128-131A region in HCMV monocyte infection
and used electron microscopy to show an accumulation of HCMV
virions in large vacuoles, suggesting that HCMV may not enter
monocytes by direct fusion at the plasma membrane [21].
Immature DCs, which are known as professional antigen
presenting cells (APCs), are characterized by their high endocytic
capacity, which allows antigen uptake and processing (for review,
see [22]). Alternatively, this fundamental property may be used by
enveloped viruses to efficiently penetrate cells, thus partly
preventing their lysosomal degradation and detection and
neutralization by the immune system and allowing the release of
viral genetic material very close to the target cell nucleus; the
required location to initiate viral replication (for review, see [16]).
Based on the ability of HCMV to interact with DC-SIGN
[23,24,25], we endeavored to demonstrate how a highly en-
dotheliotropic HCMV strain, VHL/E, that is also known to be
leukotropic and even dendrotropic [21,26,27] is internalized and
enter monocyte-derived DCs (MDDCs). Here we present evidence
that VHL/E virion internalization and entry into MDDCs occur
via a macropinocytosis-like pathway in a cholesterol-dependent
and pH-independent manner. This entry pathway was shown to
participate to the transmission of the virus from DCs to target cell
also known as trans-infection.
Materials and Methods
Ethics Satement
Human fresh blood samples were obtained from the Etablisse-
ment Franc ¸ais du Sang, the French blood donor bank (EFS,
Nantes, France). Human cells used in this study were prepared
from healthy human volunteers. As a consequence no ethics
statement is required for this work.
Cells and Ragents
Peripheral blood mononuclear cells (PBMC) were isolated from
whole blood by density centrifugation over Ficoll-Paque (Eurobio,
Les Ulis, France). Different cell populations were enriched from
PBMC by counterflow centrifuge elutriation using a Beckman
Avanti J20 centrifuge equipped with a JE-5.0 rotor and a 40 mL
elutriation chamber (Beckman Instrument Inc. Fullerton, USA).
After introduction of the PBMC suspension, remaining platelets
and red cells were elutriated first. The flow rate was increased in
order to collect lymphocytes, and finally monocytes. Elutriated
human monocytes were used to generate immature dendritic cells
according to the protocol described by Sallusto and colleagues
[28]; CD14+ cells (,95% pure) were seeded at 1 610
6 cells per
ml in RPMI 1640-10% fetal calf serum with 2 mM glutamine
supplemented with 100 ng/ml rhGM-CSF (Gentaur, Paris,
France) and 20 ng/ml rhIL-4 (Cellgenix, Freiburg, Germany)
and were cultured for five to seven days. Fully differentiated,
immature DCs displayed the following standard phenotype:
CD1a
+, CD14
neg, HLA-DR
+, CD209
+, CD80
low, CD86
low and
CD83
neg (as assessed using fluorescein isothiocyanate-conjugated
or FITC-conjugated antibodies from BD Biosciences, CA, USA).
Monocytes derived-macrophages (M1 type macrophages) were
obtained from monocytes cultured during 5 days with 10ng/ml
GM-CSF as described previously [29,30]. Human foreskin
fibroblasts (HFFs) were obtained from the Department of
Immunology and Dermatology (Pr B. Dreno, CHU Nantes,
France). HFFs were propagated in DMEM-10% fetal calf serum
with 2 mM L-glutamine media. Recombinant soluble HCMV
glycoprotein B (rec HCMV gB) was a kind gift from Biome ´rieux
(France). DAPI, AlexaFluor 488-conjugated transferrin, Alexa-
Fluor 488- or AlexaFluor 568-conjugated goat anti-mouse IgG
mAb were obtained from Molecular Probes (Eugene, OR, USA).
DMSO, 5-(N,N-dimethyl)-amiloride hydrochloride (DMA), cyto-
chalasin D, bafilomycin A1, chlorpromazine, filipin, nystatin,
methyl-b-cyclodextrin, ammonium chloride, rottlerin and Go ¨6983
were purchased from Sigma Aldrich (St. Louis, MO, USA) and
Calbiochem (San Diego, CA, USA). Conjugated antibodies
against CD14, CD1a, HLA-DR, CD80, CD83 and CD86 as well
as purified anti-CD71 (transferrin receptor) and anti-CD209 (DC-
SIGN, clone DCN46) were from Pharmingen (BD Biosciences,
CA, USA). FITC-conjugated monoclonal antibodies against
CD107b (LAMP2) and EEA1 were obtained from Pharmingen
and Transduction Laboratories, respectively (BD Biosciences,
USA). The unconjugated anti-HCMV glycoprotein B antibodies
(clones HCMV37 or 2F12 used for confocal imaging and western
blot detection, respectively) were purchased from Abcam (Cam-
bridge, UK).
Gradient Prification of HCMV Vrions
The endotheliotropic human HCMV strain VHL/E was used
in this study and other published works [31]. The virus was
propagated, purified and titered as described elsewhere [32,33].
Briefly, gradient purification of VHL/E virions was performed
with infectious supernatants from infected HFF cultures with
approximately 100% late-stage cytopathic effects that were made
cell free by centrifugation for ten minutes at 2,800 6 g.
Supernatants were then ultracentrifuged for 70 minutes at
80,000 6g. The pellets containing the virions and other particles
were resuspended in 1 ml of phosphate-buffered saline (PBS) and
were transferred onto a preformed linear glycerol-tartrate gradient
(15–35% sodium tartrate and 30–0% glycerol in 0.04% sodium
phosphate), which was then ultracentrifuged for 45 minutes at
80,000 6 g. The virion-containing band was harvested with
a syringe, and the virions were washed and pelleted by an
additional ultracentrifugation step for 70 minutes at 80,000 6 g.
The pellet was resuspended in MEM5 and stored at 280uC until it
was used for the infection experiments. The quality of the viral
stocks was assessed by negative contrast transmission electron
microscopy (Supplementary Figure S1). Usually, intact, enveloped
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purification. Quantification of the virus was assessed with a plaque-
forming assay on HFFs.
DNA Etraction and Qantitative Ral-time PCR
Viral DNA was extracted using the NucleospinH RNA virus kit
(Macherey Nagel, France) according to the manufacturer’s
instructions. A 67 bp fragment of the US8 viral gene was
amplified using a quantitative real time PCR [34]. The
oligonucleotides and probe used in this assay are as followed:
forward 59-GGCACCAAATGCAGAGTGAG-39 (CMV1RGf),
reverse 59- AAGCCGTATTCCGTTTGCG-39 (CMV2RGr)
and 59 FAM- TGGTCCAAGTCCGTGGGCACC-39 TAMRA
(CMVSRG). In order to exclude false-negative results, an internal
amplification control was included in each reaction (TaqManH
Exogenous Internal Positive Control Reagents, IPC). CMV DNA
quantitation achieved with a standard curve generated from 10-
fold serial dilutions of a plasmid containing the viral target
sequence. The HCMV DNA loads are expressed as absolute DNA
copy numbers.
Confocal Mcroscopy
Day 5 to 7 immature MDDCs were either treated or not with
the appropriate drugs for 30 minutes at 37uC. Then, cells were
infected with HCMV (MOI=2) or recombinant HCMV gB
(2 mg/ml) for various periods of time. Thereafter, the cells were
washed three times in PBS and were allowed to settle for at least
30 minutes at 37uC on poly-L-lysine-coated coverslips (overnight
pretreated with 100 mg/ml in PBS at four degrees Celsius) then
fixed for ten minutes with 4% paraformaldehyde (PFA) in PBS.
Alternatively, cells were washed with a glycine-based acidic buffer
(0.2 M, pH=2,8) immediately after the incubation step with
HCMV to remove cell-associated virions. After washing with PBS
and permeabilization at room temperature for ten minutes with
PBS containing 0.2% Triton X-100, the cells were labeled with the
appropriate primary and secondary antibodies as listed above and
were mounted in Fluoromounting Medium (Dako). Nuclei were
counterstained with DAPI as needed. The images were acquired
in immersion (oil; magnification x63) on an SP5 confocal
microscope (Leı ¨ca Microsystems, Germany).
Transmission Eectron Mcroscopy
TEM was performed at the Electronic Microscopy Facility of
the Federative Institute of Research 26 (IFR26, Nantes, France).
Briefly, day 6 MDDCs were treated with medium alone or with
inhibitors at the desired concentrations and were incubated with
VHL/E (MOI=10) for varying time periods (30 minutes, two, six
and 24 hours). Then, cells were washed with or without an
additional acidic buffer inactivation step and were resuspended in
the fixative solution (glutaraldehyde 2.5% v/v in Sorensen’s
Phosphate Buffer at 0.1 M) for two hours and a half at 4uC. Cells
were washed and post-fixed in 1% w/v osmium tetroxide for one
hour at 4uC then were dehydrated in ethanol and embedded in an
Epon resin mixture. Ultra-thin sections were double-stained using
uranyl acetate and lead citrate. Finally, thin sections (60 to 70 nm)
were cut on a Reichert Ultracut E microtome and were double-
stained using uranyl acetate and lead citrate. Observation of the
contrasted sections was done at 80 kV under a JEM-1010
transmission electron microscope (JEOL).
Cytomegalovirus Ifection Ihibition Asay
One to two hundred thousands immature MDDCs per
condition were treated with various doses of inhibitors for 30
minutes at 37uC before being incubated with the endotheliotropic
HCMV strain VHL/E (MOI=2) for two additional hours at
37uC. Thereafter, non-internalized viral particles were removed
by three washing steps (one with a low-pH glycine buffer) and
infected cells were subcultured for 24 hours at 37uC. For each
condition, a cell aliquot was kept to assess the cell viability by flow
cytometry (using propidium iodide or DAPI); the drug concentra-
tions used did not alter cell viability (data not shown). Cells were
then allowed to adhere to poly-L-lysine-coated coverslips prior to
be fixed and permeabilized with acetone and labeled for 30
minutes (37uC) with specific mAbs directed against immediate-
early and early HCMV antigens (mAbs anti-I.E.A and 2E.A,
Argene Biosoft, Varilhes, France). A goat anti-mouse IgG
polyclonal antibody conjugated to horseradish peroxidase (Dako)
was subsequently applied for 30 minutes at 37uC. After each step,
the slides were washed twice in PBS for five minutes. The presence
of antigen was visualized by staining with aminoethyl carbazole
(AEC; Argene Biosoft) for 15 minutes. After a ten minutes wash in
dH2O, the slides were counterstained with hematoxylin (Sigma)
and were mounted with glycerol/gelatin (Sigma).
Specimens incubated with isotypic antibodies (Dako) were used
as negative controls. The slides were analyzed using a computer-
based optical image analyzer (Eclipse E600 Nikon, Nikon
Instruments, Inc., NY, USA). The analyses were performed at
20-fold magnification on four distinct fields situated 100 mm apart.
The infection rate was then calculated as the mean value of the
number of infected cells counted on the four distinct fields per
condition divided by the mean value of the total number of
counted cells and multiplied by 100 (a semi-automated counting
was done using the ImageJ software).
Subcellular Factionation Assay
To determine the location of the internalized HCMV virions in
MDDCs, we adapted a subcellular fractionation assay from
Segura and colleagues [35]. Briefly, immature MDDCs (0.7–
10610
7 cells per condition) were incubated with VHL/E
(MOI=10) for two hours at 37uC. After one acidic buffer
inactivation and three additional washes in PBS, the cells were
homogenized with a cell-cracker (Kimble Chase Life Science, NJ,
USA) in homogenization buffer (PBS, 0.25 M sucrose, 10 mM
Tris, 1 mM EDTA supplemented with protease inhibitors
purchased from Roche, pH 6.8). Postnuclear supernatant (PN)
was prepared by centrifugation (1,0006g for ten minutes) and was
loaded on top of a 10% Percoll (GE Healthcare) solution in
homogenization buffer. After ultracentrifugation (50,000 6 g for
45 minutes), one mL fractions were collected. The top three
fractions (early endosomes) were pooled and concentrated by
ultracentrifugation (130,000 6 g for one hour). The bottom two
fractions were pooled and loaded on top of a 45% Percoll solution
in homogenization buffer. After ultracentrifugation (50,0006g for
45 minutes), the top three fractions (late endosomes) and the
bottom two fractions (lysosomes) were pooled and concentrated by
ultracentrifugation (130,000 6g for one hour). When needed, the
collected fractions were pooled and concentrated onto Centricon-3
filtration devices (cut-off 10 kDa; Millipore, Bedford, MA, USA)
and were frozen at 280uC until use or were instantly analyzed
with western blot.
Western Blot Analysis
Protein contents of subcellular fraction were quantified by BCA
assay (Sigma) according to the manufacturer’s instructions. In the
absence of a conserved reference protein in all subcellular fractions
obtained after cell fractionation equal amounts of total protein
were loaded on a 10% SDS/PAGE gel (Pierce Biotechnology,
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PLoS ONE | www.plosone.org 3 April 2012 | Volume 7 | Issue 4 | e34795Figure 1. CMV internalization into large uncoated vesicles in MDDCs is an active process that requires actin cytoskeleton
polymerization. A) Transmission electron microscopy (TEM) picture is shown of day 6 immature MDDCs incubated with HCMV (VHL/E; MOI=10) for
two hours then extensively washed with PBS. A scale bar is indicated (magnification x7,500). N=nucleus. B) Close-ups of different pictures are
represented. Black arrows indicate HCMV virions. A scale bar is indicated for each picture. Cells were prepared as described in 1A. C) Kinetic analysiso f
HCMV internalization in MDDCs. The data represent the quantification of the mean number of particles per cell from the TEM pictures (n$20
independent cells) of viral particles (VHL/E; MOI=10) immobilized at the plasma membrane (OUT, white bars) or internalized into vacuoles (IN, black
bars) as function of time (30 minutes, two, six and 24 hours incubations). Cells were extensively washed with PBS after incubation with HCMV. These
results are representative of two distinct experiments. D) MDDCs were pre-incubated with drugs (cytochalasin, cytD: 50-5-0.5 mM) or vehicle (DMSO:
1/100) prior to be infected with HCMV (MOI=2) for two hours. Cells were extensively washed then subcultured for 48 hours. The cells were coated
CMV Enters Dendritic Cells via Macropinocytosis
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ferred onto nitrocellulose membranes. The membrane were
stained with serum against MCP (a kind gift from Dr. Wade
Gibson, Pharmacology and Molecular Sciences, Johns Hopkins
University, Baltimore, MD, USA) or mAbs against human EEA1,
LAMP-2 and HCMV gB (clone 2F12) purchased from Abcam. A
horseradish peroxidase (HRP)-conjugated anti-mouse IgG anti-
body (Pierce) was used for protein detection.
Trans-infection Experiment
On Day 0, frozen monocytes from healthy human volunteers
were thawed and differentiated for five days toward MDDCs and
M1-typed macrophages (see the ‘‘Cells and reagents’’ part of the
Material and Method section for more information). On day 5,
another vial of monocytes from the same healthy volunteer was
thawed and all three cell types were cultured for 30 minutes with
or without Bafilomycin A1. Then, cells were infected with HCMV
(MOI=2) for two hours and afterwards extensively washed with
PBS or with a low-pH buffer. Infected cells were then co-cultured
in close contact with fibroblast monolayer. After fourty-eight
hours, fibroblasts were processed and labeled as described above
(Cytomegalovirus infection inhibition assay) to evaluate the trans-
infection by HCMV-loaded cells.
Statistical Analysis
Statistical analysis were performed using the non-parametric
Mann-Whitney test with Prism GraphPad software; p values less
than 0.05 were considered to be significant.
Results
HCMV Internalization by MDDCs is Dependent on
Cytoskeleton Remodeling
To identify the point of the entry of HCMV particles into
MDDCs, we analyzed MDDCs after short-term HCMV infection
(up to two hours) by transmission electron microscopy (TEM). We
first noted that HCMV particles were partly surrounded by cell
membrane ruffles, suggesting that actin polymerization is needed
to allow membrane remodeling and the engulfment of HCMV
virions (Figure 1A). We also observed that the vesicle contents
other than the HCMV virions were either transparent or
moderately dense to electrons, suggesting that virions may
accumulate in early endocytic vesicles of varying phenotypes and
most likely with distinct properties (Figure 1B). A few dense bodies
were also observed mixed with infectious particles but might
behave during entry as intact particles due to their envelopes
similar to those of infectious virions. The kinetics of MDDC
infection allowed us to quantify that 70% of the HCMV virions
were located in yet unknown vacuoles inside the cells, and 30% of
the virions were still bound to the plasma membrane (Figure 1C).
By six hours post-infection, all of the virions detected were
localized inside the cells (Figure 1C). To test whether HCMV
internalization is an actin-dependent process, we used cytoskeleton
pharmacological inhibitors that are able to prevent actin
polymerization and analyzed the effects of these inhibitors on
the CMV infection of MDDCs as a downstream event of the viral
entry. Day six MDDCs were pretreated with increasing concen-
trations of actin inhibitors (or vehicle controls) for 30 minutes prior
to be infected with HCMV (MOI=2) for two hours. After
extensive washes followed by 48 hours of culture, the cells were
stained for HCMV IE/E nuclear antigens and counterstained with
hematoxylin to allow total cell counting. Simultaneously, cell
viability was assessed for each condition by flow cytometric
analysis (DAPI or propidium iodide exclusion; data not shown).
When pretreated with cytochalasin D (5 mM) (Figure 1 D) or
latrunculin A1 (10 mM) (data not shown), infection of MDDCs by
HCMV was significantly impaired as compared to DMSO-treated
(vehicle) or to non-treated cells (Figure 1D), confirming that actin
remodeling is necessary for HCMV engulfment into MDDCs.
Enveloped HCMV Particles Accumulate in Large Vesicles
with Endosomal Features in MDDCs before they Undergo
Penetration by Uncoating
We sought to identify the nature of the large vesicles containing
the internalized HCMV particles we described previously. To that
purpose we infected immobilized MDDCs with the VHL/E strain
at 37uC for three and 24 hours. Then, cells were fixed/
permeabilized and labeled to characterize the location of HCMV
(red staining) into different types of organelles identified by the
early endosome antigen 1 (EEA1) and the LAMP2 markers (green
staining), which are preferentially expressed by early and late
endosomes or lysosomes, respectively. The pictures obtained with
confocal imaging are displayed in Figure 2A and 2B and were
analyzed with the ImageJ RGB profiler pluging. For both time
points, we observed some co-localization of HCMV with EEA1,
suggesting that the virus was internalized into large endocytic
vesicles matching the features of early and late endosomes.
Surprisingly, we were unable to observe colocalization between
HCMV and the LAMP2 staining, at any time points.
We performed subcellular fractionation to extract and enrich
the early/late endosomes (EE+LE) and the lysosomes (Ly).
Separation quality was assessed by western blot using antibodies
against EEA1, LAMP2. We performed the experiment using
HCMV-infected MDDCs (two hours, MOI=10). Firstly, we
looked for the presence of two viral proteins, the envelope protein
gB (160 kDa) and MCP major capsid component (153 kDa),
within the tested fractions (Figure 2C). Both viral antigens were
found at the expected molecular weight (153 kDa MCP and
160 kDa gB) only in the early and late endosome-containing
fraction. Neither MCP nor gB could be evidenced in the PN
fraction. This was most likely due to a lack of sensitivity of the
western blot assay since to obtain the endosomes- or lysosomes-
enriched fractions (ca. 200 ml) the PN fraction (7 ml) has to be 25-
to 35-fold concentrated. In the Ly, the gB was detected as a protein
of lower molecular weight as compared to the recombinant gB. In
addition, the relative amount of gB in the Ly fraction appeared to
be diminished as compared to the EE+LE fraction since equal
amount of protein were loaded on the gel. This suggests that
degradation of viral gB may have been initiated. Moreover, no
MCP was detected in the lysosome-enriched fraction. Secondly we
quantified the HCMV genome copy number in subcellular
fractions by quantitative PCR (Supplementary Figure S2). HCMV
genomic DNA could be detected in fraction containing early and
late endosomes as well as lysosomes. These results go in line with
our co-localization study described previously (Figure 2A and 2B)
and may suggest that the viral penetration could occur before the
lysosomal stage.
onto poly-L-lysine-coated slides, fixed and permeabilized with acetone and were stained with mAbs against anti-IE and –E antigens (Argene Biosoft,
France). Four distinct fields were digitalized and analyzed with ImageJ software to determine the percentage of I.E.A./E.A.+ MDDCs. n=6 independent
experiments with eight different donors in total.
doi:10.1371/journal.pone.0034795.g001
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do infect MDDCs we carefully analyzed ultrathin sections of
MDDCs inoculated for six hours with VHL/E particles to
evidence the presence of uncoated capsids in MDDCs cytoplasm.
Thus, in a substantial number of cells we simultaneously observed
a vast majority of intact virions within vesicles and structures
resembling to uncoated capsids in the cytosol (Figure 3). Re-
markably these naked capsids were usually found at the proximity
of the nuclear envelope (Figure 3). These observations strongly
suggested that at least some of the internalized HCMV particles
underwent penetration by uncoating and release of the capsid in
the cytoplasm before they may gain access to nuclear pores to
inject their DNA into the nucleus.
Finaly, we compared the internalization of whole HCMV
particles and virus-free recombinant soluble gB, both of which are
able to bind DC-SIGN [14]. We observed that whereas
recombinant gB was completely conveyed to lysosomes after only
15 minutes (complete colocalization with LAMP2), whole HCMV
virions never colocalized with the lysosomal marker LAMP2
(Supplementary Figure S3A and B), suggesting that they could be
sequestered into the previously described EEA1+ vesicles.
Although the difference in terms of size and molecular orientation
and/or multimerization between HCMV particles and virus-free
recombinant soluble gB might explain this observation, we would
like to highlight the fact that the pH of the LAMP2-positive
endosomes did not dramatically impair the staining of HCMV gB
(no epitope damage) at least for short time periods (up to 30
minutes, data not shown). When analyzing HCMV-infected
MDDCs by TEM, we observed intact particles embedded in
vesicles with low-density contents (Figure 1B). Taken together,
these results provide strong evidence that HCMV particles are
sequestered into early endosomes as intact virions.
HCMV Internalization into MDDCs Occurs Via
a Macropinocytosis-like Pathway
HCMV is one of the largest animal viruses (150–300 nm in
diameter). Considering the size of HCMV particles and based
on our own observations, we concluded that most of the
endocytic pathways (see [36] for review) except for macro-
pinocytosis could not be involved in the HCMV internalization
into MDDCs. Indeed, other herpes viruses such as Epstein-Barr
and Herplex simplex virus were shown to be endocytosed in
large uncoated vesicle and involving mechanisms suggesting
a role for macropinosomes [37]. When we analyzed MDDCs
Figure 2. Internalized HCMV virions partially co localize with EEA1 and not with LAMP2. Confocal imaging was performed on
immobilized immature MDDCs incubated for two hours on ice with the VHL/E strain (MOI=2) and subsequently cultured at 37uC for three hours (A)
and 24 hours (B). Cells were then fixed/permeabilized and immunostained as indicated above each column with anti-EEA1 or -LAMP2 antibodies
(green) and with an anti-HCMV gB (red). Images were obtained on a 510 LSM Meta (Zeiss, Germany). Single confocal planes are presented. In merged
panels, green and red staining intensities were directly analyzed along a virtual section indicated by a thin white line with the ImageJ RGB profiler
plugin. The results are displayed in graphs on the right (X-axis=distance in pixels; Y-axis=fluorescence intensity). White arrowheads indicate small
CMV aggregates or isolated particles. C) Between 7 and 10 x 10
7 HCMV-infected MDDCs (VHL/E; MOI=10) were subjected to three consecutive
subcellular fractionation steps on sucrose and Percoll gradients to harvest early and late endosome-enriched and lysosome-enriched fractions. Here
early endosomes (EE) and late endosomes (LE) enriched fractions were first pooled (EE+LE) and the EE+LE and the lysosomes (Ly) enriched fractions
were concentrated before being used in a western blot analysis using anti-EEA1, LAMP-2, HCMV gB and MCP antibodies. Recombinant HCMV gB
(Biome ´rieux, France) was used as a positive control. The molecular weight of the gB is 160 kDa and 153 kDa for the MCP. PN means post nuclear
fraction.
doi:10.1371/journal.pone.0034795.g002
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noticed HCMV particles in forming or closed large uncoated
vesicles (Figure 1A-B). We used pharmacological inhibitors of
macropinocytosis to treat MDDCs before infection with
HCMV. Amiloride, a well-known Na
+/H
+ exchanger inhibitor,
has also been widely used as a selective blocker of fluid-phase
endocytosis (FPE) and macropinocytosis in endothelial cells and
MDDCs [38]. In addition to amiloride, we tested the effect of
the PKC inhibitor Go ¨6983 on the infection of MDDCs by
HCMV. As shown in Figure 4A both amiloride (100 mM) and
GO ¨ 6983 (13 nM) significantly reduced the infection rate in
a dose-dependent manner. We obtained the same results with
the rottlerin (Suplementary Figure S4). We confirmed that the
concentration of amiloride (100 mM) used was efficient at
blocking the macropinocytosis of 70,000 Da FITC-dextran in
MDDCs (data not shown). Furthermore, TEM analysis of
amiloride-treated MDDCs infected with HCMV clearly showed
that all particles but one were docked at the plasma membrane
(Figure 4B). Of note, despite the documented efficacy of
amiloride in our study, amiloride treatment promoted only
minor changes in the number and size of filipodia-like structures
in MDDCs as compared to previous published results obtained
with epithelial cells [39,40,41]. The quantification of this
observation showed that impairment in the macropinocytosis
capability of MDDCs results in a strong defect in the entry of
HCMV into the cells (Figure 4C). Finally, chlorpromazine,
a clathrin-dependent endocytosis inhibitor, had no effect on the
infection rate, even at the highest concentration (30 mM)
(Figure 4A). Altogether, these results show that HCMV particles
are internalized into MDDCs by a macropinocytic-like pathway.
HCMV Internalization into MDDCs Occurs in
a Cholesterol-dependent Manner
We previously demonstrated that DC-SIGN is necessary for
HCMV docking on the MDDC plasma membrane [14].
Moreover, several studies have shown that DC-SIGN is organized
in cholesterol-enriched microdomains on the plasma membrane of
immature, living MDDCs [42,43,44]. Thus, we hypothesized that
HCMV internalization could involve cholesterol-enriched lipid
rafts. To confirm our hypothesis, we disrupted the cholesterol-
containing microdomains of MDDCs with increasing doses of
methyl-b-cyclodextrin (MbCD), a methylated cyclic oligosaccha-
ride that is able to solubilize cholesterol and remove it from the
plasma membrane [45]. The cells were then cultured with HCMV
for two hours and the infection rate was calculated as described
earlier. We observed that cholesterol depletion significantly
decreased the infection of MDDCs as compared to cells treated
with vehicle proving that cholesterol-enriched microdomains are
essential for the internalization of HCMV into these cells
(Figure 5A). To ensure that other types of microdomains were
not involved in the endocytic process leading to HCMV infection,
we also tested whether filipin and nystatin, both of which complex
with cholesterol in lipid rafts but do not extract it, inhibited
HCMV infection in MDDCs. Neither filipin nor nystatin had an
effect on the infection rate compared to vehicle-treated cells
(Figure 5A). Those results were rather unexpected since filipin and
nystatin do disturb cholesterol-enriched microdomains. However,
they are in accordance with previous studies reporting that filipin
and nystatin may not efficiently inhibit cholesterol-dependent
endocytosis and even in some cases may enhance it [46,47]. These
results demonstrated HCMV internalization is also dependent on
these cholesterol-enriched microdomains.
Infection of MDDCs with HCMV does not Depend on
Endosomal Acidification
Among viruses that infect mammalian cells, some require
endosomal acidification to efficiently release their capsid into the
cytoplasm. This step is commonly defined as the viral penetration.
However, in some cases, such as for Herpes simplex Virus 1 (HSV-
1), Ebola or the SARS coronavirus, a low pH is not sufficient to
induce fusion between the viral envelope and the endocytic vesicle
membrane [36,38]. Recently, it was reported that endotheliotropic
HCMV strains, which are also known to productively infect
MDDCs, use a pH-independent, but very fast, endocytic pathway
of entry into endothelial cells [1]. Based on these observations, we
wondered whether the infection of MDDCs by HCMV was
dependent on a decrease in the endosomal pH. To address this
question, we pretreated immature MDDCs with an ammonium
chloride buffer (NH4Cl) or bafilomycin A1 (BafA1), which stabilize
the endocytic pH by buffering the pH or blocking the V-ATPase
responsible for the endosomal pH decrease, respectively, before
incubation with HCMV. Ammonium chloride or bafilomycin A1
pretreatments had no effects on the rate of MDDC infection in
comparison to the vehicle alone (Figure 6A). Based on TEM, we
observed that pretreatment of MDDCs with BafA1 (50 nM) did
not impair HCMV internalization (Figure 6B) or the subsequent
steps of the infection process as described previously in this paper.
Indeed, quantification of the HCMV particles outside and inside
the bafilomycin-A1-treated MDDCs and the non-treated MDDCs
revealed no difference (Figure 6C). These results strongly suggest
Figure 3. Uncoating of internalized particles results in naked
capsids in cytoplasm of infected MDDCs. Transmission electron
microscopy (TEM) picture of a Day 6 immature MDDC incubated with
HCMV (VHL/E; MOI=10) for six hours then extensively washed with PBS.
Naked capsids in the cytoplasm are marked by arrowheads. A scale bar
is indicated in the lower left part of the micrograph (magnification
x200,000). A white dashed line indicates the nuclear envelope. N=
nucleus; C= cytoplasm.
doi:10.1371/journal.pone.0034795.g003
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HCMV into MDDCs and the infection of these cells.
Intracellularly-stocked HCMV Virions can Mediate Trans-
Infection by MDDCs
Immature DCs have been reported to have a milder endosomal
acidification than macrophages and mature DCs, leading to less
antigen degradation and processing consistent with the peptide-
loading capacities of the MHC molecules [48]. We therefore
wondered whether HCMV virions sequestered in the endosomes
of MDDCs were protected from degradation. To assess whether
the accumulated virions retained the potential to infect, we tried to
recover HCMV particles from the endosome-enriched fraction
(EE+LE). Unfortunately, we were unable to recover viral particles
without inducing irreversible damage to the particles as demon-
strated by the absence of infected HFFs when the cells were
cultured with the subcellular fractions (data not shown). We
therefore used a trans-infection experimental assay that has been
previously described [14]. We incubated MDDCs, monocyte-
derived macrophages and monocytes from the same blood donor
with HCMV for two hours. After infection, the cells were
extensively washed in PBS or in a low-pH inactivation buffer
and were placed over HFFs. When analyzing the amount of
infected HFFs, we noted that all of the tested cells, MDDCs,
macrophages and monocytes, allowed the infection of the reporter
cells regardless of whether the cells were pretreated with DMSO
or bafilomycin A1 (Figure 7, left panel). After the low-pH washes,
monocytes were not able to infect HFFs in spite of bafilomycin A1
treatment (Figure 7, right panel), suggesting that most of the effects
observed with the PBS washes were due to virions sticking the
plasma membrane. Importantly, after the low-pH washes
(Supplementary Figure S5), macrophages pretreated with DMSO
failed to trans-infect HFFs, while the inhibition of endosomal
acidification did not impair this trans-infection (Figure 7, right
Figure 4. HCMV internalization into MDDCs is impaired by macropinocytosis inhibitors. A) MDDCs were pre-incubated with drugs
blocking macropinocytosis (Go ¨6983: 13, 7.3, 3.75 nM and amiloride, Ami: 100, 20 mM) or clathrin-mediated endocytosis (chlorpromazine, CPZ: 30,
6, 1.2 mM) or with vehicle (DMSO, 1/100) prior to be infected with HCMV (MOI=2) for two hours. Cells were extensively washed then
subcultured for 48 hours. The cells were then prepared and analyzed as described in the legend for Figure 1D. For Go ¨6983, n=2 independent
experiments with 4 different donors in total, for Ami and CPZ n=5 independent experiments with 7 different donors in total. ns: not significant
(p=0,0733) B) TEM picture of (500mM) amiloride-treated MDDCs incubated with HCMV (VHL/E; MOI=10). Black arrows indicate HCMV virions. C)
Quantification of infectious HCMV particles by TEM immobilized at the plasma membrane (OUT, white bars) or internalized into vacuoles (IN,
black bars) of (500 mM) amiloride-treated MDDCs incubated for two hours with VHL/E (MOI=10) (n=6 cells per conditions). The results are
displayed as the median values of the percentage (6SD) of plasma membrane-associated and internalized HCMV particles.
doi:10.1371/journal.pone.0034795.g004
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degradation of viral particles in infected macrophages and
confirms our previous results. Pretreatment with bafilomycin A1
followed by the low-pH washes did not abrogate the trans-infection
of HFFs cells by infected MDDCs (Figure 7, right panel), but
tended to reduce it. These results confirm that infected MDDCs
likely transmit HCMV particles through close contacts between
membrane-bound virions and the plasma membrane of target cells
as the primary mechanism of trans-infection. Interestingly, these
results are in agreement with the work of Falcone and colleagues
in which they show that macropinosomes in human DC are
unique organelles able to regulate exocytoses [49]. We also showed
that after an acidic wash, cells that were free of virions sticking to
the plasma membrane were still able to trans-infect HFFs and that
this ability may be due to the protection of HCMV particles from
destruction by the mild and controlled endosomal acidification
that characterizes immature DCs.
Discussion
Human cytomegalovirus can infect and replicate in a broad
array of cell types as reflected by the pathology and epidemiology
of HCMV diseases. Because dendritic cells have been postulated to
have a role in the systemic spread of the virus, we aimed to
characterize the mechanisms of HCMV internalization/entry into
MDDCs. Indeed, the method of entry of HCMV into cells has
Figure 5. Cholesterol depletion is detrimental to the HCMV
entry into MDDCs. A) Cells were pre-incubated with filipin (7.66, 1.5,
0.3 mM), nystatin (21.2, 4.3, 0.85 mM) or methyl-b-cyclodextrin (MbCD; 5,
1, 0.2 mM) or with vehicle (DMSO, 1/100) and were processed as
described in the legend for Figure 1D. For nystatin, n= 2 independent
experiments with 2 different donors in total; for Filipin and MbCD n=4
independent experiments with 6 different donors in total. ns: not
significant (p=0,0535).
Figure 6. Endosomal pH neutralization does not inhibit HCMV internalization or MDDC infection. A) Cells were pre-incubated with
NH4Cl-containing buffer (50, 5, 0.5 mM) or bafilomycin A1 (320, 32, 3.2 nM) and compared to the vehicle (DMSO; 1/100). The cells were processed as
described in the legend for Figure 1D. For NH4Cl, n= 3 independent experiments with 3 different donors in total, for bafilomycin A1 n= 6
independent experiments with 8 different donors in total. ns: not significant (p=0,0939). B) TEM picture of (50 nM) bafilomycin A1 treated MDDCs
incubated with HCMV (VHL/E; MOI=10). Black arrows indicate HCMV virions. C) Quantification of infectious HCMV particles by TEM immobilized at
the plasma membrane (OUT, white bars) or internalized into vacuoles (IN, black bars) of (50 nM) BafA1-treated MDDCs incubated for two hours with
VHL/E (MOI=10) (n=5-6 cells per condition). The results are displayed as the median values of the percentage (6SD) of plasma membrane-
associated and internalized HCMV particles. These results are representative of two distinct experiments.
doi:10.1371/journal.pone.0034795.g006
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strains and according to how they were produced [17,18,19].
However, nothing was known about how HCMV enters MDDCs.
To that purpose, we used imaging techniques as well as
biochemical and functional assays using pharmacological inhibi-
tors to block the successive steps of HCMV infection. Using
transmission electron microscopy, we observed open or closed
filopodia-like structures in close contact with HCMV particles. We
are aware that additional experiments using the 3D focused ion
beam-scanning electron microscopy would be required to
definitely conclude on the type of cellular structures involved in
the CMV entry in MDDCs. Moreover this technology would be
also very informative and conclusive in our appreciation of the
‘‘in’’ and ‘‘out’’ status of CMV particles on the TEM images
presented in this study. Nevertheless, we observed virions
accumulation in vesicle that were usually moderately or even
markedly dense to electrons that not only suggest this observed
accumulation is located within cells but also that virions
accumulate in vesicles of varying densities. The ultrastructural
studies presented in this article show HCMV-containing, uncoated
vesicles that resemble macropinosomes in term of size (up to 1500–
2000 nm in diameter) and content, while others have shown that
HCMV entry into human retinal pigment epithelial cells occurs
through invagination of the cell membrane with the viral particles
coated on the plasma membrane [17]. Dendritic cells engulf
antigens into intracellular vesicles in an actin-dependent pathway.
Here, we demonstrated that actin polymerisation was indispens-
able for mediating the engulfment of HCMV into the endocytic
compartment of MDDCs. An actin-dependent infection pathway
was also observed by others in retinal pigment epithelial and
endothelial cells, while human foreskin fibroblast infection has
been shown to be independent of actin [17], most likely because
HCMV has been shown to enter fibroblasts by direct fusion to the
plasma membrane [20]. Cellular factors involved in virus entry by
macropinocytosis have been identified for several enveloped
viruses (HIV-1, HSV-1 and vaccinia virus), but not for HCMV
[16]. In this study, we showed that HCMV entry and subsequent
events, i.e., expression of immediate early (IE) and early (E) viral
antigens by MDDCs, involve an active, actin-dependent remodel-
ing of the plasma membrane and also depends on Na
+/H
+
exchangers, PKC activation and on the integrity of cholesterol-
enriched microdomains. We have provided strong evidence to
conclude that the HCMV infection process in MDDCs fulfills the
criteria that define macropinocytosis as previously defined by
others [16]. Our conclusions are consistent with previous studies
that reported very similar HCMV endocytic pathways in
endothelial cells with another commonly used viral strain TB40/
E [50]. We chose to focus our study on VHL/E strain on the basis
of in-house data showing that it has often a higher infectious
potential toward MDDCs than other entdotheliotropic strains
such as TB40/E although the infectious potential may also vary
between MDDC preparations for a given strain.
Because the contents of macropinosomes can either be
degraded at the late endosome/lysosome stage or recycled at the
plasma membrane by a yet unknown mechanism (see [51] and
[16] for review; [49]), we analyzed the location of internalized
HCMV virions. We observed an accumulation of enveloped
HCMV particles in the early endosome compartment. It reached
a plateau at six hours post-infection. To lead to a productive
infection, the endocytosis of enveloped viruses must be followed by
the fusion of the viral envelope and the endocytic vesicle
membranes. We have observed uncoated capsids simultaneously
close to the nuclear envelope. Interestingly we also noticed
a possible association of naked capsids with fiber-like structures we
considered as microtubules since microtubule polymerization
inhibitors such as nocodazole or colchicin did inhibit IE/E
antigen expression by CMV-infected MDDCs (data not shown).
Our work is in accordance with papers showing that CMV [52],
Kaposi’s sarcoma associated virus [53] and HSV-1 [54] do use the
microtubule network to convey their uncoated capsids to the
nucleus. Recently, it was clearly shown that in contrast to the
requirement for a drop in pH in macrophage endosomes,
dendritic cells are able to tune their endosomal pH [48] and to
keep it stable by tightly regulating the reactive oxygen species
(ROS)/H
+ balance in endo-lysosomes [55]. In DCs, a stable
endosomal pH allows a mild proteolysis that leads to an efficient
antigen processing instead of complete protein hydrolysis. We did
not observe direct fusion of the HCMV envelope at the MDDC
plasma membrane by transmission electron microscopy at rather
early time points (30 minutes pi). While a low pH and the UL128-
UL150 gene cluster are required to facilitate the penetration stage
of the TR strain into epithelial and endothelial cells [18],
fibroblasts have been shown to be infected independently of these
receptors [56,57]. This evidence for cell type-specific receptors
could explain why HCMV infection of MDDCs is not pH-
dependent. VHL/E contains the UL128-UL150 gene cluster and
was shown to still be capable of infecting MDDCs. We propose
two hypotheses to explain the pH-independent fusion. Firstly, we
cannot rule out that our viruses contain heterogeneous particles,
some containing the UL128 to UL150 genes and other missing
theses genes, which would allow some particles (i.e., those bearing
UL128-UL131A gene products) to rapidly enter and further infect
MDDCs while others would be internalized but would be unable
to promote fusion and thus be prone to accumulation in
macropinosome-like vesicles. This hypothesis is in agreement with
the results published in a recent paper [58]. Secondly, HCMV
virus is known to adapt to its host, and this pH-independent fusion
might be another example of its adaptability. It is tempting to
Figure 7. MDDCs can mediate HCMV trans-infection through
both plasma membrane-associated virions and the release of
internalized virions. MDDCs, MDMs or monocytes from the same
blood donor were obtained as described in the Materials and Methods
section. Cells were pretreated with 40 nM BafA1 (black bars) or the
vehicle (DMSO) (white bars) prior to incubation with the VHL/E HCMV
strain for two hours (MOI=2). Cells were then extensively washed with
a low-pH buffer (glycine 0.2M, pH=2.8) or with PBS alone as indicated
above each panel of the figure and were subcultured in close contact
with HFFs. After 48 hours, fibroblasts were processed as previously
described [14] to evaluate the infection rate due to trans-infection by
HCMV-loaded cells (absolute number of IE/E antigen-positive fibroblasts
among 10
5 total cells). n= 4 independent experiments with four
different donors in total.
doi:10.1371/journal.pone.0034795.g007
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to efficiently penetrate DCs without being entirely destroyed.
Further investigation is needed to elaborate on these hypotheses.
Using subcellular fractionation and western blot analyses, we
showed that envelope and capsid components, gB and MCP, were
still detectable as native full-length proteins in low- and
intermediate-density endosomes, most likely early and late
EEA1
+ endosomes. Interestingly, Falcone and colleagues have
already described similar EEA1
+ macropinosome-like vesicles
capable of internalizing and concentrating particulate antigens
such as latex beads and renamed them enlargeosomes [49]. In
addition, qPCR analyses of viral DNA in separated fractions
indicated the presence of CMV genomes in all of the tested
fractions (Supplementary Figure S3). These observations suggested
that the fusion of internalized virions might occur at the late
endosome stage in human MDDCs.
We previously demonstrated that DC-SIGN was instrumental
for specifically immobilizing HCMV particles at the MDDC
plasma membrane, allowing infection. Based on the antibody-
mediated neutralization of CMV binding to DC-SIGN, we
concluded that this interaction accounts for more than 90% of
the binding capacity of MDDCs for CMV[14]. Previous reports
have already shown that low-pH buffers (,7) strongly alter the
DC-SIGN oligomerization and most probably also its ability to
bind with high affinity to its cognate ligands, such as CMV gB
[14,59]. Although it is admitted that acidic washes do inactivate
CMV particles that bind to the plasma membrane of fibroblasts or
endothelial cells, our observations made with MDDCs provide an
alternative explanation for the acidic buffer-mediated inactivation
of plasma membrane-stuck CMV particles in our experimental
model. Indeed an acidic wash may also promote stripping of CMV
virions from outside the MDDCs (Supplementary Figure S5). In
this paper, we clearly showed that the stable endosomal pH within
the infected MDDCs protects HCMV virions from degradation
without impairing MDDC infection. Therefore, the different fates
of the macropinosomes described earlier can be observed in the
context of HCMV entry into MDDCs, and this leads to both the
infection of the cell and the capability for trans-infection.
Interestingly, a recent paper by Tacken and collegues show that
the binding of the neck region of DC-SIGN (using a monoclonal
antibody) induces an endocytosis clathrin independant and
resulted in a prolonged localization of DC-SIGN in early
endosomal compartment. On the other hand, targetting DC-
SIGN region with an anti-CDR region lead to the late endosomal
compartment [60].
DC-SIGN, either as membrane-associated oligomers or as their
soluble counterparts, clearly has a key role in HCMV infection of
MDDCs [14,61]. Located in cholesterol-enriched lipid rafts, DC-
SIGN microdomains have been shown to be essential for HIV
internalization into MDDCs [42]. Indeed, when cholesterol is
depleted from plasma membrane microdomains, the microdo-
mains are disrupted, leading to the disruption of DC-SIGN
clusters. The surface expression of DC-SIGN as single molecules
and not as clusters is thought to drastically impair high affinity
interactions between the lectin and its ligands, leading to
a blockage in viral entry [42]. Our data are in total agreement
with all these observations because we showed that the destruction
of such microdomains using methyl-b-cyclodextrin significantly
impaired MDDC infection. We therefore demonstrated that the
nanoscaled molecular DC-SIGN clusters located in cholesterol-
enriched lipid raft are also essential for HCMV internalization.
Because macropinocytosis is cholesterol-dependent, it is tempting
to hypothesize that the simple interaction of DC-SIGN with
HCMV could be sufficient to induce macropinocytosis via the
activation of DC-SIGN-dependent signaling. To our knowledge,
this would be the first documented receptor-specific, macropino-
cytosis-mediated process of virus entry [16]. However, supple-
mental experiments are needed to determine the importance of
this process in the cellular biology of DCs.
HCMV-infected MDDCs have been shown to release infectious
HCMV on Day 6 after infection with VHL/E [27]. In this paper,
we showed that 48 hours post-infection, while the late antigen
pp150 was not even expressed [27], the endosomally protected
virions were released after capture and that those particules were
remained infectious since they are able to trans-infect highly
permissive fibroblasts. It appears that HCMV has evolved to use
the highly endocytic properties of immature DCs, but not those of
monocytes or monocyte-derived macrophages, for its own benefit.
Therefore, we propose that besides the latent and replicative
viruses, a third pool of CMV might exist as a cell-protected viral
pool able to spread all over the body as a ‘‘stowaway’’ taking
advantage of the migratory properties of DCs and essentially using
the DC as a ‘‘Trojan horse’’ [62]. This observation is not only
restrited to CMV infected MDDCs. Interestingly; HIV particles
captured by DC-SIGN-expressing cells remain very stable and
infectious for several days [63]. Indeed, immature DC-mediated
HIV trans-infection has also been shown as being mediated by
exocytosis of captured HIV particles. Those exocytosed-particles
harbor exosomal antigens [64]. Internalized HCV virus like
particles were also protected from lysosomal degradation whithin
immature-DC [65] and those infected cell were able to trans-infect
Huh-7 cells [66]. In this study, we detected very few particles
inside MDDCs up to 24 hours post-infection. Previous work by the
group of Gwendalyn Randolph showed that murine DCs are able
to migrate from peripheral tissues to lymph nodes within 18 hours.
We can assume that upon internalization of infectious CMV
particles at entry sites (for example, oro-pharyngeal or ano-genital
mucosae), residing DCs may undergo their maturation/migration
program, likely leading to the release of still infectious particles in
critical locations of the human organism within less than a day
[67]. In conclusion, our data indicate that HCMV may have taken
advantage of macropinocytosis, a major process to capture
antigen, and of the mild endosomal acidification of human
immature dendritic cells to allow the protection of HCMV virions
while initiating a productive viral infection.
Supporting Information
Figure S1 Assessment of the purity of a representative
VHL/E stock preparation. TEM characterization of HCMV
preparations is shown. Virions were obtained by ultracentrifuga-
tion of end-stage VHL/E-infected human foreskin fibroblast
supernatants on a linear tartrate gradient. Picture of one viral
stock was obtained by electron microscopy of negatively stained
HCMV virions (magnification 625,000). Black arrows and
asterisks indicate intact virions and dense bodies, respectively. A
scale bar is indicated in each picture.
(TIF)
Figure S2 Titration of HCMV genomes by qPCR after
subcellular fractionation of HCMV-infected MDDCs.
The absolute number of HCMV DNA copies were quantified in
the subcellular fractions of HCMV-infected immature MDDCs
(VHL/E; MOI=10) by an in-house qPCR protocol described in
the Material and Methods section of this manuscript. The
numbers indicated above some columns in the graph represent
the indexed values of HCMV DNA copies in comparison to the
absolute HCMV DNA copy number (=100) in the postnuclear
supernatant (PN). PI means post-infection, and the values
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hours of incubation. EE=early endosome, LE=late endosome
and Ly=lysosome.
(TIF)
Figure S3 Internalized HCMV virions do not co-localize
with LAMP2 whereas a recombinant soluble HCMV gB
does. Confocal imaging of particulate (intact HCMV
particle) or soluble recombinant HCMV gB in MDDCs.
A) Co-stainings of HCMV gB (red) and LAMP-2 (green) in
MDDCs incubated for 15 minutes at 37uC with intact HCMV
particles (VHL/E strain; MOI=5; upper row). The results
displayed in the lower row show immunostaining (HCMV
gB=red and LAMP-2=green) obtained when MDDCs were
incubated with soluble recombinant HCMV gB (2 mg/ml;
Biome ´rieux, France) with the same settings reported in A. B)
Co-staining of HCMV gB (red) and transferrin receptor (green;
AlexaFluor 488-conjugated transferrin) in MDDCs incubated with
recombinant soluble HCMV gB. Images were obtained on a SP5
LSM (Leica Microsystems, Germany). DIC images are displayed
on the left side of each immunostaining. Single confocal planes are
presented. A scale bar is indicated in each DIC picture.
(TIF)
Figure S4 HCMV internalization into MDDCs is im-
paired by large spectrum PKC inhibitor. MDDCs were
pre-incubated with rottlerin shown to block PKC activation
(rottlerin 40, 13.5, 4.5 mM) and compared to the vehicle (DMSO;
1/100) prior to culturing the cells with virus (VHL/E; MOI=2)
for two hours. The cells were then prepared and analyzed as
described in the legend for Figure 1D. n= 3 independent
experiments with three different donors in total.
(TIF)
Figure S5 Acidic wash treatment allows for the strip-
ping of HCMV particles from the MDDC plasma
membrane. A) TEM pictures of MDDCs incubated with
VHL/E HCMV particles (middle and right panels; MOI=10)
or non-infected (left panel). Infected cells were washed with either
a low-pH buffer (0.2 M glycine, pH=2.8) or PBS alone and were
extensively rinsed before being processed as described in 1A. Black
arrows indicate infectious HCMV virions. B) Quantification of
infectious HCMV particles by TEM immobilized at the plasma
membrane (out, white bars) or internalized into vacuoles (in, black
bars) of HCMV-infected MDDCs (two hours with VHL/E;
MOI=10) after being washed with a glycine-based acidic buffer
(0.2M glycine, pH=2.8; +) or PBS alone (–) (n=10–15 cells per
conditions). These results are representative of at least two
independent experiments.
(TIF)
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